ArticleJournal of maxillofacial and oral surgery2025
Comparing Analgesic Efficacy of Intranasal Fentanyl Using Mucosal Atomization Device Versus Intravenous Fentanyl for Management of Breakthrough Pain in Head and Neck Cancer Patients: A Randomized Clinical Trial.
Article in Journal of maxillofacial and oral surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: The purpose of this study is to compare the analgesic efficacy of intranasal fentanyl versus intravenous fentanyl and their role in reducing the pain intensity in breakthrough pain in patients with head and neck cancer. Material and methods: This study includes 30 patients who were diagnosed with head and neck cancer and underwent surgery for the same. Patients were divided into 2 groups: group A receiving intranasal fentanyl 1 mcg/kg using mucosal atomization device and group B receiving intravenous fentanyl 1 mcg/kg when the patient complained of the breakthrough pain postoperatively; both the groups received 1 g paracetamol IV every 8 hourly. The primary outcome pain was assessed using FLACC scale. Results: Onset of action of drug was an average of 5 min in group A and 15 min in group B. No incidence of bradycardia, hypotension was seen in both the groups. Conclusions: We concluded that intranasal administration of fentanyl provides better postoperative breakthrough pain relief and opioids are the rescue medication of choice for breakthrough pain and it should be individually titrated as needed to achieve adequate pain relief while minimizing the risk of side effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.